Scientific Name: Bleomycin
Brand Name: Not Available
Company Owner: Bristol myers squibb co pharmaceutical research institute, App pharmaceuticals llc, Bedford laboratories div ben venue laboratories inc, Hospira inc, Pharmachemie bv, Teva parenteral medicines inc
Mechanism Of Action Although the exact mechanism of action of bleomycin is unknown, available evidence would seem to indicate that the main mode of action is the inhibition of DNA synthesis with some evidence of lesser inhibition of RNA and protein synthesis. As evident in
Description of the Drug: Bleomycin is a chemotherapy agent used to treat various malignancies, including head and neck malignancy, lymphoma, and testicular tumors, among others.
Protein Data Bank:
Source: DrugBank Online – Retrieved 2023-01-23 from